Literature DB >> 7473442

Efficacy of oral micronized progesterone in the treatment of luteal phase defects.

G N Frishman1, S C Klock, A A Luciano, J C Nulsen.   

Abstract

OBJECTIVE: Vaginal progesterone suppositories are an accepted treatment for infertility attributed to luteal phase defects. Although oral micronized progesterone may be preferable to suppositories for many patients, there are no studies on its use for patients with luteal phase defects. This study evaluated the efficacy of oral micronized progesterone for the treatment of luteal phase defects. STUDY
DESIGN: Seven women with luteal phase defects previously corrected by vaginal suppositories were administered oral micronized progesterone (200 mg by mouth three times a day). Endometrial biopsies were performed to evaluate treatment efficacy. Questionnaires were used to assess side effects, including sedation.
RESULTS: On oral micronized progesterone, all patients had in-phase endometrial biopsies. Despite complaints of drowsiness, the majority of patients preferred the oral formulation over the vaginal route of administration.
CONCLUSION: We conclude that oral micronized progesterone is efficacious in the treatment of luteal phase defects.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7473442

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  4 in total

1.  The effects of progesterone pretreatment on the response to oral d-amphetamine in Women.

Authors:  Stephanie C Reed; Frances R Levin; Suzette M Evans
Journal:  Horm Behav       Date:  2010-04-24       Impact factor: 3.587

2.  Open-label, Prospective, Investigator Initiated Study to Assess the Clinical Role of Oral Natural or Synthetic Progesterone During Stimulated IUI Cycles for Unexplained Infertility.

Authors:  Jaideep Malhotra; Korukonda Krishnaprasad
Journal:  J Clin Diagn Res       Date:  2016-01-01

Review 3.  Natural Micronized Progesterone Sustained Release (SR) and Luteal Phase: Role Redefined!!

Authors:  Sonia Malik; Korukonda Krishnaprasad
Journal:  J Clin Diagn Res       Date:  2016-02-01

Review 4.  A review of conventional and sustained-release formulations of oral natural micronized progesterone in obstetric indications.

Authors:  Girija Narendrakumar Wagh; K M Kundavi Shankar; Sumitra Bachani
Journal:  Drugs Context       Date:  2021-10-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.